选择性子宫动脉栓塞治疗子宫肌瘤73例临床分析

Clinical analysis of selective uterine artery embolization for hysteromyoma in 73 cases

目的观察选择性子宫动脉栓塞(uterine artery embolization,UAE)治疗子宫肌瘤的临床疗效。方法该院于2007年5月～2009年8月对73例子宫肌瘤患者进行UAE治疗,于术后3、6和12个月追踪随访,比较栓塞前后患者临床症状改善情况及肌瘤大小等指标的变化,并进行评价分析。结果 73例患者随访3～12个月,术后3、6和12个月临床症状改善明显,肌瘤体积平均缩小率为28.20%、56.50%和69.50%,无1例严重并发症发生。结论 UAE治疗子宫肌瘤具有高效、微创、安全,可保留子宫,住院时间短等优点,尤其能保留子宫的完整性,可保留患者生育功能,提高生活质量。

【Objective】 To observe the clinical curative effect of selective uterine artery embolization（UAE） in the treatment of hysteromyoma.【Methods】 Selective uterine artery embolization（UAE） was performed in 73 patients with hysteromyoma in our hospital from May 2007 to August 2009.Follow-up was finished at 3 month,6 month and 12 month after operation.The changes in clinical symptoms,the size of tumor and so on were compared before and after UAE in those patients so as to evaluate its effect.【Results】 Follow-up of 3 to 12 months was performed in 73 patients.The significant improvement in clinical symptoms occurred and the average rates of tumor size reduction at 3,6 and 12 month after operation were 28.20%,56.50% and 69.50%,respectively.No severe complication occurred.【Conclusion】 Uterine artery embolization（UAE） for hysteromyoma has advantages such as good curative effect,slight trauma,security,reservation of uterus and shorter hospital stay,especially remaining the integrality of uterus and reproductive function,and better life quality.